Contents of this document
- Acquisition of 100% of the shares of Esteve Teijin Healthcare in Spain
- Acquisition of 100% of the shares of the Coregas Group in Australia and New Zealand
- Launch of the new medium-term management plan, Next Innovation 2030
- Construction of an advanced electronics materials development building at the Tsukuba Development Center
- Construction of a new air separation unit
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | Fourth quarter of the fiscal year ended March 2026 |
| Net Sales | ¥1,359.6 billion (YoY +3.9%) |
| Operating profit | ¥197.8 billion (YoY +19.3%) |
| Net income | ¥123.8 billion (profit for the year attributable to owners of the parent) (YoY +25.4%) |
| Operating profit margin | 14.6 % |
| Results for the three months of the current quarter | Revenue ¥361.8 billion (YoY +7.5%) / Core operating profit ¥56.8 billion (YoY +15.2%) / Operating profit ¥51.7 billion (YoY +39.4%) / Quarterly profit attributable to owners of the parent ¥30.7 billion (YoY +44.4%) |
| Full-year earnings forecast | Revenue ¥1,380 billion / Core operating profit ¥208 billion / Operating profit ¥215 billion / Income before taxes ¥191 billion / Profit for the period ¥134.5 billion / Profit for the period attributable to owners of the parent ¥131 billion |
| Segment results | Japan Revenue ¥406.2 billion (YoY -0.9%) / Segment profit ¥54.1 billion (YoY +15.1%) / United States Revenue ¥360.5 billion (YoY +0.1%) / Segment profit ¥52.9 billion (YoY -11.5%) / Europe Revenue ¥350.9 billion (YoY +6.8%) / Segment profit ¥70.4 billion (YoY +12.8%) / Asia and Oceania Revenue ¥208.4 billion (YoY +18.1%) / Segment profit ¥19.7 billion (YoY +31.2%) / THERMOS Revenue ¥33.2 billion (YoY +2.1%) / Segment profit ¥6.5 billion (YoY +3.6%) |
| Breakdown of Factors Affecting the Change | Revenue Foreign-Currency Translation +1.8% / Price +1.8% / Pass-through surcharge -0.9% / Volume and sales mix -1.1% / Other +2.4% |
| Key KPIs | Basic earnings per share ¥286.22 (YoY +25.4%) / Overseas revenue ratio 68.7 % / ROE 11.3 % / ROCE 10 % / ROCE after Tax 7.1 % / Adjusted net debt-to-equity ratio 0.59 times |
| Number of employees | 20,421 people |
| Assumptions Underlying the Business Outlook | USD ¥150 / EUR ¥175 / AUD ¥100 |
| Medium-term management plan targets | NS Vision 2026 Target fiscal year Fiscal year ending March 2026 / Revenue ¥975 billion–¥1.0 trillion / Core operating profit ¥125–¥135 billion / ROCE after Tax At least 6% / Next Innovation 2030 Target fiscal year Fiscal year ending March 2030 / Revenue ¥1.5–¥1.575 trillion / Core operating profit ¥250–¥275 billion / Core operating margin 17.0% or higher / ROCE after Tax At least 8.0% |
| Financial targets | ROE Actual results 11.3 % / ROCE Actual results 10 % / ROCE after Tax Actual results 7.1 % / Adjusted net debt-to-equity ratio Actual results 0.59 times |
| Annual Dividend | ¥62 |
| Payout ratio | 21.7 % |
| Capital expenditures | ¥109.1 billion |
| New initiatives | Acquisition of 100% of the shares of Esteve Teijin Healthcare in Spain, Acquisition of 100% of the shares of the Coregas Group in Australia and New Zealand, Launch of the new medium-term management plan, Next Innovation 2030, Construction of an advanced electronics materials development building at the Tsukuba Development Center, Construction of a new air separation unit |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, price management, productivity improvement initiatives, foreign exchange translation, and acquired businesses in Europe and Australia contributed to performance. In the United States, however, lower shipment volumes of products reduced profit and had a negative impact on total volume and sales mix.